ACDI

Advanced Cell Diagnostics (ACD), a subsidiary of Bio-Techne, is a leader in the field of molecular pathology and spatial biology. The company is best known for its proprietary RNAscope technology, a highly sensitive in situ hybridization (ISH) platform that enables the visualization of single RNA molecules within intact cells and tissues. This technology provides critical spatial context to gene expression data, bridging the gap between transcriptomics and morphology. ACD's portfolio includes RNAscope, BaseScope, and miRNAscope assays, which are widely used in oncology, neuroscience, and infectious disease research. Since its acquisition by Bio-Techne in 2016, ACD has continued to innovate in the spatial genomics space, supporting both basic research and the development of companion diagnostics for pharmaceutical partners.